IP Library Granted Patent US 8,252,575
Granted Patent B2
US 8,252,575 · App. 12/986,950 · Granted Aug 28, 2012

Newly isolated bacteriophage specific to

Assignee: I-Shou University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,252,575
App. No.
12/986,950
Granted
Aug 28, 2012
Kind
B2
Abstract

A newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae , deposited at DSMZ-Deutsche Sammlung von Mikroorganismen and Zellkulturen with deposit number (DSM 24329), shows broad host ranges and lytic effects on K. pneumoniae isolated from Taiwan under either in vivo or in vitro models.

Claims (9)

1. A newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae , with the deposit number (DSM 24329), which shows broad host ranges and lytic effects on the K. pneumoniae isolated from Taiwan either in in vivo or in vitro models wherein a nucleotide sequence of the said newly isolated lytic bacteriophage comprises a plurality of EcoRV sites.

2. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the infectious titer of the newly isolated lytic bacteriophage to the K pneumoniae is 7×10 5˜7 (PFU/ml).

3. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the infectious titer of the newly isolated lytic bacteriophage to the K. pneumoniae is 2×10 5˜8 (PFU/mouse).

4. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the newly isolated lytic bacteriophage belongs to the family of Podoviridae.

5. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the newly isolated lytic bacteriophage is 40.5 kbs in full-size.

6. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the nucleotide sequence thereof comprises a plurality of HincII sites.

7. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the nucleotide sequence thereof comprises an XbaI site.

8. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the nucleotide sequence thereof comprises 11 EcoRV sites, with 10.0 kb, 8.5 kb, 6.2 kb, 3.9 kb, 2.4 kb, 2.1 kb, 1.7 kb, 1.6 kb, 1.3 kb, 0.9 kb, 0.6 kb, and 0.5 kb between each two adjacent sites respectively.

9. The newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae as defined in claim 1 , wherein the morphology of said bacteriophage comprises regular hexahedral particles when viewed under transmission electron microscopy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2011
From: TSAO, NINA; HUNG, CHIH-HSIN; KUO, CHIH-FENG
To: I-SHOU UNIVERSITY
Reel/Frame 025610/0082 →
Priority Claims (1)
TW 99105992 A · Mar 2, 2010 · national
Continuity (1)
Related Publication 20110217756A1 · Sep 8, 2011